Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-०.२१%
१,०९१.५१
-२.३०
-०.२१%
—१,०९३.८११,०९६.५२१,१००.२२१,०९१.५१——
SIXC
Communications
SIXC
Communications
SIXC
+०.२२%
६१०.११
+१.३४
+०.२२%
—६०८.७७६०८.७७६१२.९७६०८.७७——
SIXE
Energy
SIXE
Energy
SIXE
-१.३४%
१,२३७.९८
-१६.८३
-१.३४%
—१,२५४.८११,२५३.०११,२५३.८७१,२२६.३३——
SIXI
Industrials
SIXI
Industrials
SIXI
-०.९३%
१,७४४.७१
-१६.४०
-०.९३%
—१,७६१.१११,७६४.२७१,७६६.८८१,७४४.७१——
SIXM
Financials
SIXM
Financials
SIXM
-०.३७%
६४०.१८
-२.४०
-०.३७%
—६४२.५८६४४.८७६४८.४८६४०.१८——
SIXR
Staples
SIXR
Staples
SIXR
-०.१८%
८४९.५८
-१.५५
-०.१८%
—८५१.१३८५५.६६८५८.७५८४५.५६——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-०.२३%
२१७.४८
-०.५०
-०.२३%
—२१७.९८२१७.९८२१८.६५२१६.८८——
SIXT
Technology
SIXT
Technology
SIXT
+१.५२%
३,२६०.६९
+४८.८६
+१.५२%
—३,२११.८३३,२२७.२१३,२६८.३८३,२२६.५५——
SIXU
Utilities
SIXU
Utilities
SIXU
-०.६९%
९४२.४५
-६.५३
-०.६९%
—९४८.९८९४८.५८९५७.८३९४१.९७——
SIXV
Health care
SIXV
Health care
SIXV
-०.५२%
१,४६६.८०
-७.७२
-०.५२%
—१,४७४.५२१,४७९.०३१,४८१.०४१,४६६.८०——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+०.२२%
२,३९७.५०
+५.३८
+०.२२%
—२,३९२.१२२,३९६.९५२,४२१.२२२,३८२.३२——
SHTDY:OTCMKTS
Sinopharm Group ADR
US$ ११.८८
+०.३४%
(+०.०४०) 1D
मे १, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SHTDY...
Open
US$ ११.६१
High
US$ ११.८८
Low
US$ ११.६१
Mkt. cap
५७.६४ अरब
Avg. vol.
६३.३८ हजार
Volume
६२.०९ हजार
52-wk high
US$ १४.८७
52-wk low
US$ १०.८४
Beta
०.३०
Shares outstanding
२६.८४ करोड
No. of employees
९५ हजार
News stories
From sources across the web
Profile
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical. Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted. Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
About Sinopharm Group ADR
CEO-
Employees९४.९ हजार
Founded२००३
Headquarters-
Sector-
Websitesinopharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
Revenue
१.४४ खरब
१.४५ खरब
१.४४ खरब
१७.८२ अरब
Cost of goods sold
१.३४ खरब
१.३५ खरब
१.३३ खरब
१७.४५ अरब
Cost of revenue
१.३४ खरब
१.३५ खरब
१.३३ खरब
१७.४५ अरब
Research and development expenses
-६.३३ करोड
१७.२६ करोड
-१७.२६ करोड
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
६.०८ अरब
५.१७ अरब
७.३४ अरब
-
Operating expense
५.९२ अरब
६.८० अरब
५.०० अरब
-
Total operating expenses
१.४० खरब
१.४१ खरब
१.३८ खरब
१७.४५ अरब
Operating income
४.५४ अरब
४.१२ अरब
५.४० अरब
३७.६६ करोड
Other non operating income
-७.०१ करोड
१२.०८ करोड
-४२.७४ करोड
२.७४ लाख
EBT including unusual items
४.२७ अरब
३.६७ अरब
३.९२ अरब
३७.६९ करोड
EBT excluding unusual items
४.४४ अरब
३.५१ अरब
५.३६ अरब
३७.६९ करोड
Income tax expense
१.१८ अरब
९०.५४ करोड
१.१९ अरब
८.९४ करोड
Effective tax rate
२७.७६%
२४.६६%
३०.३०%
२३.७२%
Other operating expenses
-५१.४८ करोड
९१.७१ करोड
-१.१० अरब
-
Net income
२.०१ अरब
१.८४ अरब
१.८५ अरब
२८.७५ करोड
Net profit margin
१.३९%
१.२७%
१.२९%
१.६१%
Earnings per share
-
-
-
-
Interest and investment income
-
३६.४२ करोड
-
-
Interest expense
-७१.१० करोड
-४१.२६ करोड
-८४.६६ करोड
-
Net interest expenses
-७१.१० करोड
-४.८३ करोड
-८४.६६ करोड
-
Depreciation and amortization charges
-
-
-
-
EBITDA
५.१० अरब
४.६६ अरब
५.९१ अरब
९४.०९ करोड
Gain or loss from assets sale
-१.१८ करोड
१.१८ करोड
-२.०५ करोड
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer